It is also recommended that the current voluntary restriction on insurers» ability to ask for predictive genetic
test results should be renewed, in the light of public concerns over
genomic data disclosure to insurers and the risk that this might result in many «refusing their consent to
receive additional findings from whole genome sequencing».